India’s tryst with the IVF technology started way back in the year 1986, when Harsha Chawda became India’s first test tube baby, a feat that made IVF specialist Dr Indira Hinduja a household name in the country. Harsha was born with the help of In vitro fertilization (IVF). Since its inception, IVF technology has fulfilled many dreams and the IVF market has also grown manifold over the years. Industry experts predict that the market is going to thrive further at a startling rate and is expected to become an INR 490 crore (approx) industry by the end of 2022.
Though the overall growth of this industry is hampered by the outbreak of the pandemic, experts in the field are optimistic about the revival of the market. The major stakeholders of this industry believe that the induction of some of the cutting-edge technology will decide the future course of IVF industry in India.
Speaking about the development, Nitiz Murdia, Co-founder and Director at Indira IVF said, “We understand that infertility in India is not only a medical condition, but it also comes with societal consequences. Couples undergoing treatment face a host of challenges, and uncertainty related to outcome – has become a major concern. Thus, the assurance that an IVF cycle will lead to a successful pregnancy is paramount.”
Indira IVF, India’s leading fertility chain credits its clinical success rate to their commitment in implementing advanced technologies like – Electronic Witnessing systems and Closed Working Chambers across its centres. Indira IVF was the first organisation in the country to have conducted over 100,000 procedures and has established itself as the largest infertility specialist clinic-chains in India.
The Electronic Witnessing Technology imported from Denmark and the Closed Working Chambers Technology from Australia address two very critical facets of assisted reproductive techniques (ART). The former utilises RFID (radio frequency identification) chips that are tagged on test tubes of sperm samples and dishes where eggs are stored, ensuring and monitoring that there is no mix-up of unrelated samples. Closed Working Chambers provide a controlled and suitable environment, similar to the human body, for the handling of these samples; this provides clean and safe processes that increase the likelihood of success by manifold.
“With the aid of these unique, advanced cutting-edge technologies from abroad, we are making an attempt to give equal access to all who trust us for their treatment and also to help put their mind at ease. It is by means of empathy and meticulous standardisation processes that we have been able to attain a 74% success rate at Indira IVF so far,” Murdia added.
Dr. Rajeev Kayestha, Regional Director (N/W) of Cooper Surgical, the company that provides the Electronic Witnessing technology, RI Witness™, to Indira IVF said “We are proud to partner with Indira IVF – the biggest employer of our technology in the country. Given the fact that IVF specialists work on several procedures at a time, the RI Witness™ technology is a full proof system that completely eliminates the chances of any kind of mix-up at all stages of an IVF procedure.”
The foundation for Indira IVF is set on the principle of increasing access to affordable state-of-the-art IVF treatment to aspiring individuals and couples. The introduction of these technologies furthers this cause and empowers people to take control of their reproductive health.
Witnessing a huge influx of inquiries from Tier II and Tier III cities, and in its effort to provide affordable and best in class treatment, the company have now added five new centres in cities like Nanded, Warangal, Sirsa, Gulbarga, Ujjain, and a latest one in Noida. This takes Indira IVF’s total number of centres to 94 nationally.
